MTANZ Publications
|
|
|
|
(Adobe PDF) 1773KB
|
|
Deloitte Report - June 2019
|
|
|
|
|
(Adobe PDF) 1214KB
|
|
MTANZ INDUSTRY SURVEY Click here to view the NZ Medical Technology Industry Report Key facts and figures 2015
|
|
|
|
|
(Adobe PDF) 2197KB
|
|
Deloitte was engaged by MTANZ to develop a white paper to present to PHARMAC and form the basis for on-going discussions with regard to the procurement of medical devices. Deloitte, as an independent organisation was able to interview a broad spectrum of stakeholders; clinicians, societies and industry. The paper “Hospital medical device decision criteria” is now finalised and can be downloaded here.
|
|
|
|
|
(Adobe PDF) 761KB
|
|
New Zealand faces some major challenges in providing access to innovative, cost-effective and safe medical technology in the future.
Although it's been thought that new medical technologies are the main driviers of increasing healthcare costs this is not the case. Rather, innovative medical technology may offer solutions as we have outlined in this document.
We discuss issues including: What is the value of the New Zealand investment in medical technology? Why is it important to maintain clinical choice in selecting medical technology? How should we measure cost-effectiveness of medical devices? Where to from here.
Please call MTANZ on (09) 917 3645 if you require a hard copy of this document.
|
|
|
|
|
(Adobe PDF) 833KB
|
|
This document provides a window into the New Zealand medical technology industry.
In these pages, you will find information about who we are and what we do. You will see the critical role we play in delivering and improving healthcare to New Zealanders, by guaranteeing the accessibility, affordability and availability of the best and most advanced medical technology devices.
Please call MTANZ on (09) 917 3645 if you require a hard copy of this document.
|
|
|
|
|
(Adobe PDF) 327KB
|
|
Submissions
|
|
|
|
(Adobe PDF) 557KB
|
|
|
|
|
(Adobe PDF) 516KB
|
|
|
|
|
(MS Word 2007) 204KB
|
|
This document and covering letter answers the relevant questions posed in PHARMAC's discussion document. Although specifically for wound care devices MTANZ responded on the assumption that the model would apply to other device categories.
|
|
|
|
|
(Adobe PDF) 442KB
|
|
This consultation document is directed to clinicians, but MTANZ wishes to respond because the medical technology industry¡¦s relationship with clinicians is crucial for procurement decisions and both are co-dependent.
New Zealanders need affordable access to innovative and effective medical technology that improves health outcomes by: - Reducing disease, disability and hospitalization - Increasing the safety and efficacy of treatment - Increasing life expectancy - Shortening hospital stays - Increasing the potential
|
|
Position Papers
|
|
|
|
(Adobe PDF) 183KB
|
|
|
|
|
(Adobe PDF) 153KB
|
|